Evidence map›Paper›PMID 21571675›Full record

ArticleInvestigative ophthalmology & visual science2011

Regulation of fibronectin-EDA through CTGF domain-specific interactions with TGFβ2 and its receptor TGFβRII.

Rima Khankan, Noelynn Oliver, Shikun He, Stephen J Ryan, David R Hinton

Open access · bronzeAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 37 citations in OpenAlex.

  1. Trial
  2. Article
  3. Proliferative Vitreoretinopathy: A Reappraisal.Journal of clinical medicine · 2023
    Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Changes in cardiac resident fibroblast physiology and phenotype in aging.American journal of physiology. Heart and circulatory physiology · 2018
    Review
  11. Article
  12. CTGF Contributes to the Development of Posterior Capsule Opacification: anInternational journal of biological sciences · 2018
    Article
  13. Article
  14. Minireview: Fibronectin in retinal disease.Experimental biology and medicine (Maywood, N.J.) · 2017
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Connective tissue growth factor is involved in structural retinal vascular changes in long-term experimental diabetes.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2014
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Rima KhankanDepartment of Pathology, Keck School of Medicine of the University of Southern California, Los Angeles, California, USA.
Noelynn Oliver
Shikun He
Stephen J Ryan
David R Hinton
FibroGen (United States) · USUniversity of Southern California · US

Funding

VISION RESEARCHP30EY003040 · NEI · DOHENY EYE INSTITUTE · PI SUN, DEMING · 1985 to 2013
$7.0M
EXPERIMENTAL APPROACH TO MACULOPATHYR01EY001545 · NEI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HINTON, DAVID R. · 1985 to 2016
$6.0M
NEI NIH HHS EY01545NEI NIH HHS EY03040NEI NIH HHS P30 EY003040NEI NIH HHS R01 EY001545
6 · The paper itself

Abstract

purposeTo investigate the role of fibronectin containing extra domain A (FN-EDA) in the pathogenesis of proliferative vitreoretinopathy (PVR) and the regulation of FN-EDA by transforming growth factor (TGF)-β and connective tissue growth factor (CTGF) in retinal pigment epithelial (RPE) cells.

methodsExpression of FN-EDA in normal human retinas and PVR membranes was evaluated by immunohistochemistry. The effects of TGFβ and CTGF on FN-EDA mRNA and protein expression in primary cultures of human RPE cells were analyzed at different time points by real-time PCR and Western blot, respectively. The interaction of CTGF with TGFβ2 or with its type II receptor TGFβRII was examined by ELISA, immunoprecipitation, and solid-phase binding assays.

resultsFN-EDA was abundantly expressed in PVR membranes but absent from the RPE monolayer in normal human retinas. Treatment of RPE cells with TGFβ2 induced FN-EDA expression in a time- and dose-dependent manner, but CTGF alone had no effect. However, CTGF, through its N-terminal half fragment, augmented TGFβ2-induced expression of FN-EDA at the protein level. This effect was blocked by antibodies against TGFβ2 or TGFβRII. Interaction of TGFβ2 or TGFβRII with CTGF was dose dependent and specific. CTGF directly bound TGFβ2 and TGFβRII at its N- and C-terminal domains, respectively.

conclusionsThese findings suggest that CTGF promotes the profibrotic activities of TGFβ acting as a cofactor through direct protein interactions and complex regulatory mechanisms.

Indexed as

Blotting, WesternCells, CulturedConnective Tissue Growth FactorEnzyme-Linked Immunosorbent AssayFibronectinsGene Expression RegulationHumansImmunoenzyme TechniquesProtein Interaction Domains and MotifsProtein Serine-Threonine KinasesReceptors, Transforming Growth Factor betaReceptor, Transforming Growth Factor-beta Type IIRetinaRetinal Pigment EpitheliumReverse Transcriptase Polymerase Chain ReactionRNACCN2 protein, humanConnective Tissue Growth FactorFibronectinsProtein Serine-Threonine KinasesReceptors, Transforming Growth Factor betaReceptor, Transforming Growth Factor-beta Type IIRNARNA, MessengerTransforming Growth Factor beta2

Identifiers

PMID21571675
PMCPMC3176038
OpenAlexW2084247690

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.